Brazil OKs Fourth COVID-19 Vaccine, But Knocks Back Bharat Biotech
Regulator Evaluating New Application For Sputnik V
Janssen’s Ad26.COV2-S is the latest COVID-19 vaccine to be authorized for emergency use in Brazil. The country’s drugs agency has also received an emergency use request from Lilly for its monoclonal antibody combination, banlanivimab and etesevimab, for treating COVID-19.
